ONTARGET: Use of ramipril, telmisartan, or both in patients with high cardiovascular risks

被引：0
|
作者：
HoWon Lee
Amgad N. Makaryus
Samy I. McFarlane
机构：
来源：
Current Diabetes Reports | 2009年 / 9卷 / 3期
关键词：
Chronic Heart Failure; Valsartan; Ramipril; Candesartan; Telmisartan;
D O I：
10.1007/s11892-009-0030-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 187
页数：2
相关论文
共 50 条
  • [31] Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
    Mancia, Giuseppe
    Schumacher, Helmut
    Redon, Josep
    Verdecchia, Paolo
    Schmieder, Roland
    Jennings, Garry
    Yusoff, Khalid
    Ryden, Lars
    Liu, G. Lisheng
    Teo, Koon
    Sleight, Peter
    Yusuf, Salim
    CIRCULATION, 2011, 124 (16) : 1727 - U94
  • [32] Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
    Horn, S.
    JOURNAL FUR HYPERTONIE, 2013, 17 (02): : 74 - 75
  • [33] Ramipril and telmisartan: Equally effective for patients at high risk of vascular events?
    不详
    JOURNAL OF FAMILY PRACTICE, 2008, 57 (07): : 443 - 443
  • [34] Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients:: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)
    Boehm, Michael
    Baumhaekel, Manus
    Probstfield, Jeffrey L.
    Schmieder, Roland
    Yusuf, Salim
    Zhao, Feng
    Koon, Teo
    AMERICAN HEART JOURNAL, 2007, 154 (01) : 94 - 101
  • [35] Therapy of patients at high risk for vascular events, Telmisartan, ramipril or a combination?
    Duesing, R.
    Nitschmann, S.
    INTERNIST, 2008, 49 (09): : 1137 - 1140
  • [36] Both ramipril and telmisartan reverse left ventricular diastolic dysfunction in patients with type II diabetes
    Koulouris, S
    Symeonides, P
    Triantafylloy, K
    Karabinos, I
    Kranidis, A
    Vratsista, E
    Michaelides, I
    Katritsis, D
    Manolis, A
    CIRCULATION, 2004, 110 (17) : 787 - 787
  • [37] Therapy of patients at high risk for vascular events, Telmisartan, ramipril or a combination? [Therapie von vaskulären hochrisikopatienten: Telmisartan, ramipril oder eine kombination?]
    Düsing R.
    Nitschmann S.
    Der Internist, 2008, 49 (9): : 1137 - 1140
  • [38] Both ramipril and telmisartan favourably affect indices of early diabetic cardiomyopathy
    Koulouris, S
    Symeonides, P
    Triantafyllou, K
    Vratsista, E
    Karabinos, I
    Kranidis, A
    Nanas, I
    Stamatelopoulos, S
    Toutouzas, P
    Manolis, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 170A - 170A
  • [39] Telmisartan for the management of patients at high cardiovascular risk
    Ruilope, Luis M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) : 1673 - 1682
  • [40] Ramipril: A review of its use in preventing cardiovascular outcomes in high-risk patients
    Anderson V.R.
    Perry C.M.
    Robinson D.M.
    American Journal of Cardiovascular Drugs, 2006, 6 (6) : 417 - 432
12345